NASDAQ : VRTX

Vertex Pharmaceuticals Incorporated — Stock Grades

$477.36 USD

$4.27 (0.9%)

Volume
1.25M
Average Volume
1.52M
Market Capitalization
$121.16B
P/E Ratio
28.06
Dividend Yield
0.00%
Price Target
$576.00
Year High
$533.67
Year Low
$362.50
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$3.02
VRTX Stock Grades
Date Grading Company Previous Grade New Grade Action
2026-07-13 Truist Securities Buy Buy Maintain
2026-07-13 UBS Buy Buy Maintain
2026-07-07 Baird Underperform Underperform Maintain
2026-07-07 RBC Capital Outperform Outperform Maintain
2026-05-06 Barclays Overweight Overweight Maintain
2026-05-05 Morgan Stanley Overweight Overweight Maintain
2026-05-05 Bernstein Outperform Outperform Maintain
2026-05-05 Canaccord Genuity Hold Hold Maintain
2026-05-05 RBC Capital Outperform Outperform Maintain
2026-04-30 Canaccord Genuity Hold Hold Maintain
2026-04-10 Morgan Stanley Overweight Overweight Maintain
2026-03-18 Maxim Group Hold Buy Upgrade
2026-03-11 Truist Securities Buy Buy Maintain
2026-03-10 B of A Securities Buy Buy Maintain
2026-03-10 Oppenheimer Outperform Outperform Maintain
2026-03-10 HC Wainwright & Co. Buy Buy Maintain
2026-03-10 Morgan Stanley Overweight Overweight Maintain
2026-03-10 Citigroup Buy Buy Maintain
2026-02-17 Canaccord Genuity Hold Hold Maintain
2026-02-17 Barclays Overweight Overweight Maintain
2026-02-17 HC Wainwright& Co. Buy Buy Maintain
2026-02-17 HC Wainwright & Co. Buy Buy Maintain
2026-02-13 Scotiabank Sector Perform Sector Perform Maintain
2026-02-13 RBC Capital Outperform Outperform Maintain
2026-02-13 Stifel Hold Hold Maintain
2026-02-13 HC Wainwright & Co. Buy Buy Maintain
2026-02-13 Oppenheimer Perform Outperform Upgrade
2026-01-28 Barclays Equal Weight Overweight Upgrade
2026-01-26 UBS Buy Buy Maintain
2026-01-23 Evercore ISI Group Outperform Outperform Maintain
2026-01-22 RBC Capital Sector Perform Outperform Upgrade
2026-01-12 Bernstein Market Perform Outperform Upgrade
2026-01-06 Wolfe Research Peer Perform Outperform Upgrade